Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-14-000090
Filing Date
2014-11-10
Accepted
2014-11-10 16:16:20
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-201493010qdoc.htm 10-Q 1586632
2 RATIO OF EARNINGS TO FIXED CHARGES pdli-201493010qex121.htm EX-12.1 57868
3 CERTIFICATION pdli-201493010qex311.htm EX-31.1 10977
4 CERTIFICATION pdli-201493010qex312.htm EX-31.2 11229
5 CERTIFICATION pdli-201493010qex321.htm EX-32.1 14265
12 LOGO pdl-logoa05a01a01.jpg GRAPHIC 59351
  Complete submission text file 0000882104-14-000090.txt   12395771

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20140930.xml EX-101.INS 2159069
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20140930.xsd EX-101.SCH 86643
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20140930_cal.xml EX-101.CAL 94125
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20140930_def.xml EX-101.DEF 324846
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20140930_lab.xml EX-101.LAB 757664
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20140930_pre.xml EX-101.PRE 475550
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 141208856
SIC: 2836 Biological Products, (No Diagnostic Substances)